Keith Blundy
Directeur/Membre du Conseil chez Nodus Oncology Ltd.
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Scott Doak | M | 62 |
Nodus Oncology Ltd.
Nodus Oncology Ltd. BiotechnologyHealth Technology Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell. | - |
Ian Waddell | M | 61 |
Nodus Oncology Ltd.
Nodus Oncology Ltd. BiotechnologyHealth Technology Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell. | - |
Nicola Broughton | M | - |
Nodus Oncology Ltd.
Nodus Oncology Ltd. BiotechnologyHealth Technology Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell. | 2 ans |
Clare Wareing | M | 61 |
Nodus Oncology Ltd.
Nodus Oncology Ltd. BiotechnologyHealth Technology Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell. | - |
Bert Klebl | M | - |
Nodus Oncology Ltd.
Nodus Oncology Ltd. BiotechnologyHealth Technology Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell. | - |
Julia Mary Brown | F | 58 |
Nodus Oncology Ltd.
Nodus Oncology Ltd. BiotechnologyHealth Technology Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell. | 2 ans |
Manuelle Debunne | M | - |
Nodus Oncology Ltd.
Nodus Oncology Ltd. BiotechnologyHealth Technology Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell. | 2 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Statistiques
Pays | Relations | % du total |
---|---|---|
Royaume-Uni | 7 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Keith Blundy
- Réseau Personnel